File(s) not publicly available
Differential Involvement of Glutamatergic Mechanisms in the Cognitive and Subjective Effects of Smoking
journal contribution
posted on 2023-06-07, 18:08 authored by A Jackson, J Nesic, C Groombridge, O Clowry, Jennifer Rusted, Dora DukaThere is growing preclinical evidence for the involvement of glutamate in the behavioral actions of nicotine. The aim of this study, was to investigate the role of N-methyl-D-aspartate (NMDA) receptors in the cognitive and subjective effects of smoking in humans. Sixty regular smokers took part in this double-blind placebo controlled study, that investigated the effect of the NMDA-antagonist memantine (40mg) and the nicotinic-receptor antagonist mecamylamine (10mg) on smoking-induced improvement in performance of a task of sustained attention and on smoking-induced changes in subjective effects and craving. Increases in subjective ratings of `buzzed¿ following smoking were reversed by memantine, but not by mecamylamine. In contrast, improvement on a Rapid Visual Information Processing task by smoking was opposed by mecamylamine, but not by memantine. Smoking reduced craving for cigarettes, but neither drug altered this effect. Our results suggest that glutamatergic mechanisms may have differential involvement in the subjective and cognitive actions of smoking. Further investigations using different ligands are warranted to fully characterize the role of glutamate underlying the consequences of smoking behavior.
History
Publication status
- Published
Journal
NeuropsychopharmacologyISSN
0893-133XPublisher
Nature Publishing GroupExternal DOI
Issue
2Volume
34Page range
257-265Pages
9.0Department affiliated with
- Psychology Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC